JPS5919945B2 - Method for producing 2-aminothiazol-4-yl-α-oximinoacetic acid derivative - Google Patents

Method for producing 2-aminothiazol-4-yl-α-oximinoacetic acid derivative

Info

Publication number
JPS5919945B2
JPS5919945B2 JP56197327A JP19732781A JPS5919945B2 JP S5919945 B2 JPS5919945 B2 JP S5919945B2 JP 56197327 A JP56197327 A JP 56197327A JP 19732781 A JP19732781 A JP 19732781A JP S5919945 B2 JPS5919945 B2 JP S5919945B2
Authority
JP
Japan
Prior art keywords
groups
aminothiazol
producing
protecting group
acid derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56197327A
Other languages
Japanese (ja)
Other versions
JPS57140776A (en
Inventor
道彦 落合
泰一 岡田
修躬 安芸
明 森本
健二 川喜多
義弘 松下
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Priority to JP56197327A priority Critical patent/JPS5919945B2/en
Publication of JPS57140776A publication Critical patent/JPS57140776A/en
Publication of JPS5919945B2 publication Critical patent/JPS5919945B2/en
Expired legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Thiazole And Isothizaole Compounds (AREA)

Description

【発明の詳細な説明】 本発明は、一般式 、、゛゛゛゛□、。[Detailed description of the invention] The present invention is based on the general formula ,,゛゛゛゛□,.

。0、、0、、 30〔式中、−COORIは保護されていてもよいカル
ボキシル基を、R2NH−は保護されていてもよいアミ
ノ基を示す。
. 0, 0, 30 [In the formula, -COORI represents an optionally protected carboxyl group, and R2NH- represents an optionally protected amino group.

〕で表わされる2−アミノチアゾールー4−イルーα−
オキシミノ酢酸誘導体の製造法に関するものである。3
5本発明者等は、種々研究した結果、一般式〔式中、X
はハロゲン原子を、−COORlは前記と同意義を示す
] 2-aminothiazole-4-yl α-
The present invention relates to a method for producing oximinoacetic acid derivatives. 3
5 As a result of various studies, the present inventors found that the general formula [wherein,
represents a halogen atom, and -COORl has the same meaning as above.

〕で表わされるα−オキシミノβ−ケト−γ−ハロゲノ
酪酸エステル類と一般式〔式中、R2NH− は前記と
同意義。
[In the formula, R2NH- has the same meaning as above.

〕で表わされるチオ尿素化合物とを反応させ、必要に応
じて保護基を除去すると2−アミノチアゾール−4イル
一α−オキシミノ酢酸誘導体〔1〕が得られること、お
よび得られた化合物〔〕が優れた抗菌作用を有するペニ
シリン類またはセフアロスポリン類の有用な合成中間体
であることを見出し、これに基づいて本発明を完成した
。即ち、本発明は、α−オキシミノ一β−ケトγ−ハロ
ゲノ酪酸エステル類〔〕とチオ尿素化合物〔〕とを反応
させ、必要に応じて保護基を除去することを特徴とする
2−アミノチアゾール−4−イル一α−オキシミノ酢酸
誘導体〔1〕の製造法に関するものである。
2-aminothiazol-4yl-α-oximinoacetic acid derivative [1] can be obtained by reacting with a thiourea compound represented by It was discovered that the compound is a useful synthetic intermediate for penicillins or cephalosporins that have excellent antibacterial activity, and the present invention was completed based on this finding. That is, the present invention provides a 2-aminothiazole, which is characterized by reacting an α-oximino-β-ketoγ-halogenobutyric acid ester [ ] with a thiourea compound [ ] and removing the protecting group as necessary. This invention relates to a method for producing -4-yl-α-oximinoacetic acid derivative [1].

上記式中−COORlは、保護されていてもよいカルボ
キシル基を示し、従つてR1は水素原子あるいはカルボ
キシル基の保護基を示す。
In the above formula, -COORl represents an optionally protected carboxyl group, and therefore R1 represents a hydrogen atom or a protecting group for the carboxyl group.

このような保護基としては、チアゾール核に影響を与え
ることなく酸性条件、アルカリ性条件、還元条件等の緩
和な条件で除去しうるものなら何でもよく、たとえば一
般にペプチド合成においてカルボキシル基の保護基とし
て用いられるものから選択され、たとえばメチル、エチ
ル、プロピル、イソプロピル、ブチル、第2ブチル、イ
ソブチル、第3ブチルなどのアルキル基、β−メチルス
ルホニルエチル、トリクロルエチル、ジフエニルメチル
などの置換アルキル基、フエニル、トリルなどのアリー
ル基、p一第3ブチルフエニル、p−ニトロフエニルな
どの置換アリール基、ベンジル、フエネチル、トルベン
ジルなどのアラルキル基、p−メトキシベンジル、p−
ニトロベンジルなどの置換アラルキル基などが用いられ
る。R2NH− は、保護されていてもよいアミノ基を
示し、従つてR2は水素原子あるいはアミノ基の保護基
を示す。このような保護基としては、ペプチド化学一般
に使用される脱離容易なアミノ基の保護基が用いられ、
たとえばホルミル、アセチル、プロピオニルなどのアル
キルカルボニル基、t−ブトキシカルボニルなどのアル
コキシカルボニル基、メトキシアセチル、メトキシプロ
ピオニルなどのアルコキシアルキルカルボニル基、トリ
クロルエトキシカルボニルなどの置換アルコキシカルボ
ニル基、メトキシカルボニルアセチルなどのアルコキシ
カルボニルアセチル基、ベンジルオキシカルボニルなど
のアラルキルオキシカルボニル基、p−ニトロベンジル
オキシカルボニルなどの置換アラルキルオキシカルボニ
ル基などが繁用される。Xは、塩素、臭素、ヨム素、フ
ツ素などのハロゲン原子を示す。本発明の目的化合物〔
1〕は、α−オキシミノβ−ケト−γ−ハロゲノ酪酸エ
ステル類〔〕とチオ尿素化合物〔〕とを反応させること
により製造することができる。この反応は、たとえばエ
タノール、テトラヒドロフランなどの有機溶媒中で行な
われる。溶媒には塩基を添加するのがよく、このような
塩基としては、たとえばピリジン、トリエチルアミン、
N−N−ジメチルアニリンなどの第三級塩基が用いられ
る。R2が水素原子の場合には、〔〕自体が塩基として
作用するのでさらに塩基を加える必要はない。反応は、
.室温ないし還流条件下有利に進行する。反応終了後、
目的物〔1〕を分離しまたは分離せずに、必要に応じて
保護基の除去を行なうことができる。保護基の除去は、
各々の保護基の除去に通常用いられる手段が用いられ、
たとえばエチル、プロピルなどのアルキル基は酸または
アルカリによつて、ジフエニルメチルなどのジアリール
アルキル基、pメトキシベンジルなどのアルコキシアラ
ルキル基は酸によつて、β−メチルスルホニルエチルな
どのメチルスルホニルアルキル基はアルカリによつて、
β・β・β一トリクロルエチルなどのハロゲノアルキル
基は亜鉛と酸によつて、p−ニトロベンジルなどのp−
ニトロアラルキル基は接触還元.によつて容易に行なう
ことができる。アミノ基の保護基R2の除去は、たとえ
ばβ・β・β一トリクロルエトキシカルボニルなどのハ
ロゲノアルコキシカルボニル基は亜鉛と酸によつて、ホ
ルミル基、t−ブトキシカルボニルなどの第3級アルコ
キシカルボニル基は酸によつて、p−ニトロベンジルオ
キシカルボニルなどの置換アラルキルオキシカルボニル
基は接触還元によつて容易に行なうことができる。カル
ボキシル基およびアミノ基がいずれも保護されている場
合には、これらの保護基は同時に行なつてもよく、また
保護基の種類を考慮していずれかを先に除去してもよい
。得られる目的物〔1〕は、公知の手段たとえば溶媒抽
出、転溶、液性変換、結晶化、再結晶、蒸留、クロマト
グラフイ一、イオン交換などにより単離精製することが
できるが、分離することなく反応液のまま次の工程の原
料に供することもできる。かくして得られる本願目的化
合物〔〕は、優れた抗菌力を持つ6位または7位に2−
アミノチアゾール−4−イルグリシルアミド基を有する
ペニシリン類またはセフアロスポリン類の製造に有利な
新規中間体である。
Any type of protecting group may be used as long as it can be removed under mild conditions such as acidic conditions, alkaline conditions, reducing conditions, etc. without affecting the thiazole nucleus; for example, it is generally used as a protecting group for carboxyl groups in peptide synthesis. For example, alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, isobutyl, tert-butyl, substituted alkyl groups such as β-methylsulfonylethyl, trichloroethyl, diphenylmethyl, phenyl, tolyl. Aryl groups such as p-tert-butylphenyl, substituted aryl groups such as p-nitrophenyl, aralkyl groups such as benzyl, phenethyl, tolbenzyl, p-methoxybenzyl, p-
Substituted aralkyl groups such as nitrobenzyl are used. R2NH- represents an optionally protected amino group, and therefore R2 represents a hydrogen atom or a protecting group for the amino group. As such a protecting group, a protecting group for an amino group that is easily removed and is commonly used in peptide chemistry is used.
For example, alkylcarbonyl groups such as formyl, acetyl, and propionyl; alkoxycarbonyl groups such as t-butoxycarbonyl; alkoxyalkylcarbonyl groups such as methoxyacetyl and methoxypropionyl; substituted alkoxycarbonyl groups such as trichloroethoxycarbonyl; and alkoxycarbonyl groups such as methoxycarbonylacetyl. Carbonylacetyl groups, aralkyloxycarbonyl groups such as benzyloxycarbonyl, and substituted aralkyloxycarbonyl groups such as p-nitrobenzyloxycarbonyl are frequently used. X represents a halogen atom such as chlorine, bromine, iodine, or fluorine. Target compound of the present invention [
1] can be produced by reacting α-oximino β-keto-γ-halogenobutyric acid esters [] and a thiourea compound []. This reaction is carried out in an organic solvent such as ethanol or tetrahydrofuran. A base is preferably added to the solvent, such as pyridine, triethylamine,
A tertiary base such as N-N-dimethylaniline is used. When R2 is a hydrogen atom, [] itself acts as a base, so there is no need to further add a base. The reaction is
.. The process advantageously proceeds at room temperature to reflux conditions. After the reaction is complete,
The protecting group can be removed as necessary, with or without separating the target product [1]. Removal of the protecting group is
Means commonly used for the removal of each protecting group are used;
For example, alkyl groups such as ethyl and propyl can be treated with acids or alkalis, diarylalkyl groups such as diphenylmethyl, alkoxyaralkyl groups such as p-methoxybenzyl can be treated with acids, and methylsulfonylalkyl groups such as β-methylsulfonylethyl can be treated with alkalis. According to
Halogenoalkyl groups such as β, β, and β-trichloroethyl can be converted to p-nitrobenzyl by zinc and acid.
Catalytic reduction of nitroaralkyl groups. This can be easily done by The protective group R2 of an amino group can be removed by using zinc and acid for halogenoalkoxycarbonyl groups such as β, β, and β-trichloroethoxycarbonyl, and for tertiary alkoxycarbonyl groups such as formyl and t-butoxycarbonyl. With acids, substituted aralkyloxycarbonyl groups such as p-nitrobenzyloxycarbonyl can be easily achieved by catalytic reduction. When both the carboxyl group and the amino group are protected, these protecting groups may be applied at the same time, or one of them may be removed first, taking into account the type of protecting group. The obtained target product [1] can be isolated and purified by known means such as solvent extraction, dissolution, liquid conversion, crystallization, recrystallization, distillation, chromatography, ion exchange, etc. The reaction solution can also be used as a raw material for the next step without further treatment. The object compound of the present application [ ] obtained in this way has a 2-2-
It is a novel intermediate useful for the production of penicillins or cephalosporins having an aminothiazol-4-ylglycylamide group.

実施例 1 α−オキシミノ一β−オキソ一γ−クロロ酪酸エチル1
9.3f7、チオ尿素8.07をエタノール200m1
に溶解し2時間加熱還流する。
Example 1 Ethyl α-oximino-β-oxo-γ-chlorobutyrate 1
9.3f7, thiourea 8.07 in ethanol 200ml
and heated under reflux for 2 hours.

エタノールを減圧下留去し、残留物を10%塩酸に溶解
する。この溶液から未反応のα−オキシミノ一βオキソ
一γ−クロロ酪酸エチルを除去するためにエーテル各2
00m1で2回洗浄したのち、これに炭酸水素ナトリウ
ムを加えてPH7.O〜7.5に調整しクロロホルム各
100m1で2回抽出する。クロロホルム層を水洗、乾
燥後クロロホルムを留去して2−アミノチアゾール−4
−イル一α−オキシミノ酢酸エチルが得られる。収量6
.4370本品は融点137〜138℃(分解点)を示
す。赤外線吸収スペクトル(NujOl)は3430?
−1にオキシムの1710(1771−1にエステルの
吸収を示す。実施例 2 α−オキシミノ一β−ケト−γ−ブロモ酪酸工し、これ
にN−(β・β・β一トリクロロエトキシカルボニル)
チオ尿素251ηを加えて6時間加熱し還流させる。
Ethanol was distilled off under reduced pressure, and the residue was dissolved in 10% hydrochloric acid. To remove unreacted ethyl α-oximino-β-oxo-γ-chlorobutyrate from this solution,
After washing twice with 00ml, sodium hydrogen carbonate was added to the solution to adjust the pH to 7. Adjust the temperature to 0 to 7.5 and extract twice with 100 ml each of chloroform. After washing the chloroform layer with water and drying, chloroform was distilled off to obtain 2-aminothiazole-4.
Ethyl -yl-alpha-oximinoacetate is obtained. Yield 6
.. 4370 This product has a melting point of 137-138°C (decomposition point). Is the infrared absorption spectrum (NujOl) 3430?
oxime 1710 (1771-1 shows the absorption of ester)
Add 251η of thiourea and heat to reflux for 6 hours.

冷却後、反応混合物にクロロホルム50m1を加えて水
洗し、硫酸マグネシウムで乾燥する。クロロホルムを減
圧留去したのち、シリカゲルカラムクロマトにより精製
して、2(β・β・β一トリクロロエトキシカルボニル
アミノ)チアゾール−4−イル一α−オキシミノ酢酸エ
チルエステルを得る。収量160m9。つ本品の核磁気
共鳴スペクトル(100MHz、重クロロホルム中)は
1.35および4.36ppmにエチル基の三重線およ
び四重線、4.87ppmにトリクロロエトキシ基の単
線、7。
After cooling, 50 ml of chloroform is added to the reaction mixture, washed with water, and dried over magnesium sulfate. After chloroform is distilled off under reduced pressure, the residue is purified by silica gel column chromatography to obtain 2(β·β·β-trichloroethoxycarbonylamino)thiazol-4-yl-α-oximinoacetic acid ethyl ester. Yield 160m9. The nuclear magnetic resonance spectrum (100 MHz, in deuterated chloroform) of this product shows triplet and quartet lines of ethyl group at 1.35 and 4.36 ppm, single line of trichloroethoxy group at 4.87 ppm, 7.

94ppmにチアゾール5位水素の単線共鳴線を示す。A single resonance line of hydrogen at the 5-position of thiazole is shown at 94 ppm.

参考例 (1)実施例1で得た2−アミノチアゾール−4イル一
α−オキシミノ酢酸エチル2.15yを50%ギ酸20
m1とメタノール10m1の混合物・に溶解する。
Reference Example (1) 2.15y of ethyl 2-aminothiazol-4yl-α-oximinoacetate obtained in Example 1 was mixed with 20% of 50% formic acid.
Dissolve in a mixture of ml and 10ml of methanol.

氷冷下攪拌しながらこれに亜鉛末1.5Vを少量ずつ加
え3時間攪拌を続けたのち不溶物を沢去する。沢液を減
圧下濃縮して粗製の2−アミノチアゾール−4−イルグ
リシンエチルを含有する溶液を得る。これをそのまま強
酸性イオン交換樹脂(H型)アンバーライトIR−12
060m1からなるカラムに通し水洗を繰り返してギ酸
を除く。この後10%アンモニア水で溶出し、溶出液を
減圧下濃縮して2一アミノチアゾール一4−イルグリシ
ンが得られる。収量1.497(収率86.4%)。本
品は含水エタノールから再結晶して精製され融点186
〜190℃(分解点)を示す。核磁気共鳴スペクトル(
60Mc、 トリフルオロ酢酸中)で5.25ppmに
側鎖メチン水素の単線、6.75ppmにチアゾール環
上水素の単線共鳴線を示す。
While stirring under ice-cooling, 1.5V of zinc powder was added little by little to the mixture, stirring was continued for 3 hours, and then insoluble materials were removed. The solution is concentrated under reduced pressure to obtain a solution containing crude 2-aminothiazol-4-ylglycineethyl. Add this as is to strong acidic ion exchange resin (H type) Amberlite IR-12.
The formic acid is removed by passing through a column consisting of 0.060 ml and repeated washing with water. Thereafter, the eluate was eluted with 10% aqueous ammonia, and the eluate was concentrated under reduced pressure to obtain 2-aminothiazole-4-ylglycine. Yield: 1.497 (yield: 86.4%). This product is purified by recrystallization from aqueous ethanol and has a melting point of 186.
~190°C (decomposition point). Nuclear magnetic resonance spectrum (
60Mc in trifluoroacetic acid), a single line of side chain methine hydrogen at 5.25 ppm and a single line resonance line of hydrogen on the thiazole ring at 6.75 ppm are shown.

ニンヒドリン試薬で紫色を呈する。(2) 2−アミノ
チアゾール−4−イルグリシン3.46VをN−N−ジ
メチルアセトアミド100m1にけんだくする。
Gives a purple color with ninhydrin reagent. (2) Suspend 3.46V of 2-aminothiazol-4-ylglycine in 100ml of N-N-dimethylacetamide.

室温で攪拌しながら、β・β・β一トリクロルエトキシ
カルボニルクロリド12.66f7を30分間で滴下す
る。さらに30分間撹拌したのち、反応混合物に酢酸エ
チル250m1を加える。1規定塩酸70m1で洗浄し
たのち酢酸エチル層を分離する。
While stirring at room temperature, 12.66f7 of β·β·β monotrichloroethoxycarbonyl chloride is added dropwise over 30 minutes. After stirring for a further 30 minutes, 250 ml of ethyl acetate are added to the reaction mixture. After washing with 70 ml of 1N hydrochloric acid, the ethyl acetate layer was separated.

Claims (1)

【特許請求の範囲】 1 一般式 ▲数式、化学式、表等があります▼ 〔式中、Xはハロゲン原子を、−COOR^1は保護さ
れていてもよいカルボキシル基を示す。 〕で表わされるα−オキシミノ−β−ケト−γ−ハロゲ
ノ酪酸エステル類と一般式▲数式、化学式、表等があり
ます▼ 〔式中、R^2NH−は保護されていてもよいアミノ基
を示す。 〕で表わされるチオ尿素化合物とを反応させ、必要に応
じて保護基を除去することを特徴とする一般式▲数式、
化学式、表等があります▼ 〔式中、−COOR^1およびR^2NH−は前記と同
意義。 〕で表わされる2−アミノチアゾール−4−イル−α−
オキシミノ酢酸誘導体の製造法。
[Claims] 1 General formula ▲ Numerical formulas, chemical formulas, tables, etc. ▼ [In the formula, X represents a halogen atom, and -COOR^1 represents an optionally protected carboxyl group. ] α-oximino-β-keto-γ-halogenobutyric acid esters and the general formula ▲ Numerical formulas, chemical formulas, tables, etc. . A general formula ▲ which is characterized by reacting with a thiourea compound represented by ] and removing the protecting group as necessary,
There are chemical formulas, tables, etc. ▼ [In the formula, -COOR^1 and R^2NH- have the same meanings as above. ] 2-aminothiazol-4-yl-α-
Method for producing oximinoacetic acid derivatives.
JP56197327A 1981-12-07 1981-12-07 Method for producing 2-aminothiazol-4-yl-α-oximinoacetic acid derivative Expired JPS5919945B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56197327A JPS5919945B2 (en) 1981-12-07 1981-12-07 Method for producing 2-aminothiazol-4-yl-α-oximinoacetic acid derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56197327A JPS5919945B2 (en) 1981-12-07 1981-12-07 Method for producing 2-aminothiazol-4-yl-α-oximinoacetic acid derivative

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP49146567A Division JPS5760345B2 (en) 1974-12-19 1974-12-19

Publications (2)

Publication Number Publication Date
JPS57140776A JPS57140776A (en) 1982-08-31
JPS5919945B2 true JPS5919945B2 (en) 1984-05-09

Family

ID=16372616

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56197327A Expired JPS5919945B2 (en) 1981-12-07 1981-12-07 Method for producing 2-aminothiazol-4-yl-α-oximinoacetic acid derivative

Country Status (1)

Country Link
JP (1) JPS5919945B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61184807U (en) * 1985-05-09 1986-11-18
JPH0419693U (en) * 1990-06-05 1992-02-19
JPH0419694U (en) * 1990-06-05 1992-02-19
JPH0430296U (en) * 1990-07-07 1992-03-11

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010002705A (en) * 1999-06-17 2001-01-15 고두모 A new method for preparation of reactive phosphate derivatives of thiazole carboxylic acid

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61184807U (en) * 1985-05-09 1986-11-18
JPH0419693U (en) * 1990-06-05 1992-02-19
JPH0419694U (en) * 1990-06-05 1992-02-19
JPH0430296U (en) * 1990-07-07 1992-03-11

Also Published As

Publication number Publication date
JPS57140776A (en) 1982-08-31

Similar Documents

Publication Publication Date Title
US4008246A (en) Aminothiazole derivatives
AU635174B2 (en) Cephalosporin compounds, processes for their preparation and antibacterial agents
JPH02311483A (en) Preparation of ceftriaxone
US4608373A (en) Cephem compounds
JPS5919945B2 (en) Method for producing 2-aminothiazol-4-yl-α-oximinoacetic acid derivative
US3887606A (en) Process for the preparation of DL-phenylglycine esters
US4690921A (en) Cephalosporin compounds and salts thereof
US5574155A (en) Process for the synthesis of the disodium salt hemiheptahydrate of ceftriaxone
JP2003513983A (en) Method for producing high-purity cefpodoxime proxetil
EP0018546A2 (en) Process for the production of phenylglycyl chloride hydrochlorides
EP0481118B1 (en) A method for producing butyl 3'-(1H-tetrazol-5-yl) oxanilate
US4193918A (en) Process for the preparation of hydroxy-alpha-amino-benzyl penicillin
US3644347A (en) 3-aminomethyl cephalosporin compounds
CA1072951A (en) Reactive penicillanic acid and cephalosporanic acid derivatives and a process for the preparation thereof
CA1077951A (en) Process for antibiotic fr 1923 and related compounds
US5288860A (en) Process for preparing thiazolino azetidinone and 2-exo-methylenepenam derivative
US4652652A (en) Thiazolylpropenedicarboxylic acid half esters and process for making
JPS5919101B2 (en) 2-aminothiazol-4-yl-α-oximinoacetic acid derivative
US5142040A (en) Process for preparing a 3-formylcephem derivative
US4767851A (en) Process for the preparation of 7-amino and 7-substituted amino-desacetoxycephalosporins
KR800001549B1 (en) Preparing process for thiayolyl acetate
US3399207A (en) Esters of 6-aminopenicillanic acid
GB2036723A (en) Mercaptoacylpiperazine carboxylic acid compounds
US4182868A (en) 7-Methoxycephalosporin derivatives
US4301072A (en) Process for preparing aminopenicillins